AI-powered proteins for a healthier future.
Designed with intelligence.
Rooted in biology.
OUR APPROACH
AI-enabled protein design is a new frontier for unlocking breakthrough therapeutics.
We are pioneering the translation of AI-designed proteins for therapeutic applications that have enormous potential to improve patient outcomes.
Targeted RadioTherapy (TRT) / Oncology
- Solid tumor indications
- Mono- & multi-specifics
Long-Acting Injectables (LAI)
- Non-oncology indications
- Mono- & multi-specifics
We generate development candidates that combine numerous differentiating properties
OUR APPROACH
We are a team of experimentalists, clinicians, and innovators at heart who are grounded in our shared drive to create new meaningful medicines for patients.
Our accomplished team combines talented entrepreneurs, scientists, and seasoned biotech professionals with a proven track record of delivering for patients and investors.
Together at Lila, we are boldly defining the future of next-generation protein therapeutics for both oncology and non-oncology indications.
1. A deep understanding of disease biology and unmet patient needs.
2. Deploy Lila’s unrivaled AI-powered protein design engine and high-throughput discovery and research platform (LILADDTM).
3. Discover and optimize therapeutics with a highly differentiated target product profile (TPP).
Using this approach, we have built a diverse portfolio of molecules and are uniquely positioned to deliver transformative medicines for cancer and non-oncology patients.
.png)
OUR MISSION
To leverage AI-powered protein design and other cutting-edge approaches to unlock transformative medicines that improve the quality of life of patients suffering from cancer and other debilitating diseases.
OUR VISION
We’re rapidly entering a new world of superintelligence. In this new world, AI-enabled protein design and drug development will unlock breakthrough therapeutics for a healthier future. Lila is committed to becoming a world leader in the innovation that delivers this transformative future to medicine and patients.
Our Team
WRF
SilverArc
Sahsen
Boom
Alexandria Venture Investments
Pack VC
Cooley
Targeted RadioTx (TRT)
Cardio-Pulmonary LAIs
CAREER
Join us on our mission to make transformative medicines for patients.
